Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the CRISPR-Based Diagnostics Market From 2025 To 2029?
The market size for Crispr-based diagnostics has been on a steady rise recently, with predictions of an increase from $4.35 billion in 2024 to $5.1 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.3%. Factors contributing to this growth during the historical period include an increase in healthcare spending, rising demand for gene editing, growing incidence of chronic illnesses, heightened awareness of available treatments, and a surge in genetic diseases prevalence.
The market size for CRISPR-based diagnostics is projected to experience fast expansion in the coming years, escalating to $9.77 billion in 2029 with a CAGR of 17.6%. The surge during the prediction period can be associated with an increasing need for swift and precise diagnostics, an increased use in detecting infectious diseases, governmental and institutional financial support, better identification of antibiotic resistance, and heightened awareness and acceptance of CRISPR technologies. Key trends during the forecast period extend to point-of-care testing, CRISPR-Cas12 and Cas13 systems, individualized medicine and genetic screening, fusion with nanotechnology and biosensors, as well as early disease detection with CRISPR.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20734&type=smp
Which Factors and External Forces Are Driving Demand in the CRISPR-Based Diagnostics Market?
The escalating occurrence of infectious diseases is predicted to drive the expansion of the CRISPR-based diagnostics market. Diseases caused by pathogenic organisms like bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between people or through infested surfaces, food, water, or insects, constitute infectious diseases. The prevalence of these diseases is increasing due to variables such as globalization, resistance to antibiotics, climate change, urbanization, population expansion, habitat destruction, and inadequate access to healthcare. Rapid and accurate detection of pathogens through CRISPR-based diagnostics boost the fight against these diseases, enabling early diagnosis, timely intervention, and effective containment measures. For instance, the UK Health Security Agency, a UK-based executive agency, reported in August 2024, a near sevenfold jump to 368 measles cases in 2023 from 53 cases reported in 2022 in England; the West Midlands and London accounted for 44% and 33% of these cases respectively. Consequently, the increasing occurrence of infectious diseases is fuelling the growth of the CRISPR-based diagnostics market.
Which Segments in the CRISPR-Based Diagnostics Offer the Most Growth?
The crispr-based diagnosticsmarket covered in this report is segmented –
1) By Product: Kits; Buffer Solutions; Software; Other Products
2) By Technique: Recombinase Polymerase Amplification (RPA); Loop-mediated Isothermal Amplification (LAMP); Other Techniques
3) By Disease: Infectious Diseases; Non-Infectious Diseases
4) By End-User: Hospitals; Diagnostic Centers; Biotechnology Companies; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Kits: CRISPR Detection Kits; CRISPR Amplification Kits; CRISPR-Based Assay Kits
2) By Buffer Solutions: CRISPR Reaction Buffers; CRISPR Lysis Buffers
3) By Software: CRISPR Data Analysis Software; CRISPR Design Software; CRISPR Diagnostic Platforms Software
4) By Other Products: CRISPR Enzymes; CRISPR Reagents; CRISPR-Based Probes
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20734&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the CRISPR-Based Diagnostics Market?# Market?
North America was the largest region in the CRISPR-based diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR-based diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theCRISPR-Based Diagnostics Market’s Growth?
Leading corporations involved in the CRISPR-based diagnostics market are targeting the implementation of strategic collaborations to broaden the scope of quick and accurate diagnostics through CRISPR-based point-of-care examinations. Such an alliance is a long-term co-operation between various organizations sharing resources and skills to accomplish combined aims and strengthen their competitive position. For example, in August 2023, CrisprBits Private Limited, a biotechnology company based in India, made public a strategic alliance with Molbio Diagnostics, an India-based company specializing in molecular diagnostics, to formulate CRISPR-based Point-of-Care Tests (POCTs). This collaboration is centered around producing quick, accurate, and cost-efficient diagnostic instruments employing CRISPR technology for the detection of pathogens and genetic markers. These POCTs are designed to improve diagnostic accessibility in various environments, including those with limited resources, while providing rapid and correct disease diagnosis. This partnership amalgamates CrisprBits’ proficiency in CRISPR-based platforms with Molbio’s manufacturing and supply capacity, allowing these tests to reach a worldwide market.
View the full report here:
https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report
What Are the Key Elements That Define the CRISPR-Based Diagnostics Market?
CRISPR (clustered regularly interspaced short palindromic repeats)-based diagnostics refers to advanced molecular tools leveraging the CRISPR-Cas system to detect specific nucleic acid sequences with high precision and speed for identifying diseases or genetic markers, offering revolutionary capabilities in medical and genomic analysis. These diagnostics are utilized in applications such as detecting infectious diseases, identifying genetic disorders, and monitoring mutations in cancer research and treatment, with growing potential in personalized medicine and point-of-care testing.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20734
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model